Biondo Investment Advisors, LLC Edwards Lifesciences Corp Transaction History

Biondo Investment Advisors, LLC

$670 Million
Q2 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$61.71 - $77.76 $66,338 - $83,592	-1,075 Reduced 0.94%	113,634 $8.66 Million
Q3 2023 Nov 09, 2023	BUY	$69.28 - $93.38 $5,750 - $7,750	83 Added 0.07%	114,709 $7.95 Million
Q2 2023 Aug 11, 2023	SELL	$81.41 - $94.33 $145,072 - $168,096	-1,782 Reduced 1.53%	114,626 $10.8 Million
Q1 2023 May 09, 2023	BUY	$74.26 - $84.51 $34,827 - $39,635	469 Added 0.4%	116,408 $9.63 Million
Q4 2022 Feb 09, 2023	BUY	$68.3 - $87.44 $19,260 - $24,658	282 Added 0.24%	115,939 $8.65 Million
Q3 2022 Nov 07, 2022	BUY	$82.37 - $107.29 $7,660 - $9,977	93 Added 0.08%	115,657 $9.56 Million
Q2 2022 Aug 11, 2022	SELL	$86.5 - $128.27 $319,531 - $473,829	-3,694 Reduced 3.1%	115,564 $11 Million
Q1 2022 May 12, 2022	SELL	$101.96 - $128.34 $22,941 - $28,876	-225 Reduced 0.19%	119,258 $14 Million
Q4 2021 Feb 08, 2022	SELL	$106.37 - $130.68 $384,527 - $472,408	-3,615 Reduced 2.94%	119,483 $15.5 Million
Q3 2021 Nov 09, 2021	BUY	$102.91 - $122.75 $113,715 - $135,638	1,105 Added 0.91%	123,098 $13.9 Million
Q2 2021 Aug 03, 2021	SELL	$83.84 - $104.76 $20,037 - $25,037	-239 Reduced 0.2%	121,993 $12.6 Million
Q1 2021 May 11, 2021	SELL	$78.68 - $90.67 $541,239 - $623,718	-6,879 Reduced 5.33%	122,232 $10.2 Million
Q4 2020 Feb 04, 2021	BUY	$71.69 - $91.23 $119,722 - $152,354	1,670 Added 1.31%	129,111 $11.8 Million
Q3 2020 Nov 05, 2020	BUY	$67.19 - $87.44 $3.34 Million - $4.34 Million	49,690 Added 63.91%	127,441 $10.2 Million
Q2 2020 Aug 07, 2020	BUY	$57.54 - $76.95 $3.15 Million - $4.22 Million	54,794 Added 238.68%	77,751 $5.37 Million
Q1 2020 May 08, 2020	BUY	$52.41 - $81.0 $786,778 - $1.22 Million	15,012 Added 188.95%	22,957 $4.33 Million
Q4 2019 Feb 06, 2020	BUY	$71.7 - $82.09 $185,344 - $212,202	2,585 Added 48.23%	7,945 $1.85 Million
Q3 2019 Nov 05, 2019	BUY	$61.55 - $75.43 $108,943 - $133,511	1,770 Added 49.3%	5,360 $1.18 Million
Q2 2019 Aug 06, 2019	BUY	$55.74 - $64.41 $2,229 - $2,576	40 Added 1.13%	3,590 $663,000
Q1 2019 May 08, 2019	BUY	$47.89 - $64.05 $83,807 - $112,087	1,750 Added 97.22%	3,550 $679,000
Q4 2018 Feb 08, 2019	BUY	$46.41 - $56.94 $3,480 - $4,270	75 Added 4.35%	1,800 $276,000
Q3 2018 Nov 07, 2018	BUY	$45.7 - $58.03 $2,285 - $2,901	50 Added 2.99%	1,725 $300,000
Q1 2018 May 02, 2018	BUY	$37.19 - $47.45 $62,293 - $79,478	1,675 New	1,675 $234,000

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

469M

Call Options Held

2.44M

Put Options Held

2.65M

Vanguard Group Inc Valley Forge, PA

53.6M
Shares

$3.51 Billion
0.1% of portfolio
Black Rock Inc. New York, NY

51M
Shares

$3.34 Billion
0.11% of portfolio
State Street Corp Boston, MA

26M
Shares

$1.7 Billion
0.11% of portfolio
Alliancebernstein L.P. New York, NY

20.3M
Shares

$1.33 Billion
0.68% of portfolio
Wellington Management Group LLP Boston, MA

16.9M
Shares

$1.11 Billion
0.29% of portfolio

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Biondo Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Biondo Investment Advisors, LLC with notifications on news.

Account